Full Text View
Tabular View
No Study Results Posted
Related Studies
Genetics, Metabolism and Weight Loss in Older, Obese Veterans
This study has been completed.
First Received: July 3, 2001   Last Updated: January 20, 2009   History of Changes
Sponsored by: Department of Veterans Affairs
Information provided by: Department of Veterans Affairs
ClinicalTrials.gov Identifier: NCT00018330
  Purpose

This study is designed to determine whether sequence variation in the lipoprotein lipase (LPQ) gene affects the amount of weight loss and metabolic responses during a hypocaloric diet treatment for overweight and obese (BMI=25-35 kg/m2), older (50-65 yrs), sedentary veterans.


Condition Intervention
Obesity
Behavioral: Weight Loss

Study Type: Interventional
Study Design: Treatment, Non-Randomized, Uncontrolled, Single Group Assignment, Efficacy Study
Official Title: Genetics, Metabolism and Weight Loss in Older, Obese Veterans

Resource links provided by NLM:


Further study details as provided by Department of Veterans Affairs:

Study Start Date: April 1999
Estimated Study Completion Date: March 2004
Detailed Description:

Veterans who are 50-65 yrs, non-smoking, sedentary and weight stable with a BMI between 25-35 kg/m2 (120-150% desirable body weight) are recruited and screened via telephone, medical history, and physical exam. Exclusion criteria are: diabetes, hypertriglyceridemia (>400 mg/dl), history of cancer or myocardial infarction, clinical depression, renal, liver or hematologic disease, and medications that affect glucose or lipid metabolism (thiazides, estrogen replacement, beta-blockers). Changes in total and visceral body fat are measured by dual x-ray absorptiometry and computerized tomography, resting energy expenditure and fat oxidation rate by indirect calorimetry, and lipoprotein lipids by enzymatic assay. Glucose tolerance is assessed during a three-hour oral glucose tolerance test with measurement of glucose- and insulin levels every 30 minutes. LPL activity is measured in 3050mg pieces of subcutaneous abdominal and gluteal adipose tissue.

  Eligibility

Ages Eligible for Study:   50 Years to 65 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Criteria
  • 50-65 yrs, non-smoking, sedentary and weight stable with a BMI between 25-35 kg/m2 (120-150% desirable body weight) are recruited and screened via telephone, medical history, and physical exam.

Exclusion criteria:

  • Diabetes,
  • Hypertriglyceridemia (>400 mg/dl),
  • History of cancer or myocardial infarction,
  • Clinical depression,
  • Renal, liver or hematologic disease, and
  • Medications that affect glucose or lipid metabolism (thiazides, estrogen replacement, beta-blockers).
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00018330

Locations
United States, Maryland
VA Maryland Health Care System
Baltimore, Maryland, United States, 21201
Sponsors and Collaborators
  More Information

No publications provided

Study ID Numbers: AGCG-006-98F
Study First Received: July 3, 2001
Last Updated: January 20, 2009
ClinicalTrials.gov Identifier: NCT00018330     History of Changes
Health Authority: United States: Federal Government

Keywords provided by Department of Veterans Affairs:
Behavioral
Weight Loss
Genetics
Lipoprotein lipase
Visceral fat
Lipoprotein

Study placed in the following topic categories:
Body Weight
Signs and Symptoms
Obesity
Weight Loss
Body Weight Changes
Nutrition Disorders
Overweight
Overnutrition

Additional relevant MeSH terms:
Body Weight
Signs and Symptoms
Obesity
Weight Loss
Body Weight Changes
Nutrition Disorders
Overweight
Overnutrition

ClinicalTrials.gov processed this record on July 02, 2009